Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 52, Issue 7
Volume 52, Issue 7
1 April 2011
ISSN 1058-4838
EISSN 1537-6591

Volume 52, Issue 7, 1 April 2011

1 April News

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages i–ii, https://doi.org/10.1093/cid/cir113

In the Literature

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages iii–iv, https://doi.org/10.1093/cid/cir096

ARTICLES AND COMMENTARIES

David Orlikowski and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 837–844, https://doi.org/10.1093/cid/cir074

The risk to develop GBS is similar following CMV or C. jejuni infection. The number of cases has been decreasing over time but displays an annual periodicity. CMV-GBS mostly occurs in young adults and in women aged >50. Sensory defects are frequent and could be related to viral replication.

Michael Lunn and Richard Hughes
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 845–847, https://doi.org/10.1093/cid/cir082
Mitchell J. Schwaber and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 848–855, https://doi.org/10.1093/cid/cir025

During 2006, Israeli hospitals faced a clonal outbreak of carbapenem-resistant Klebsiella pneumoniae, threatening the entire hospital system. A centrally-coordinated nationwide intervention, including isolation of hospitalized carriers, dedicated staffing, and professional oversight, succeeded in containing the spread, after local measures failed.

Itay Wiser and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 856–861, https://doi.org/10.1093/cid/cir006

We compared the level of vaccinia immune markers among subjects who did or did not develop clinical take following smallpox revaccination, and found similar levels in both groups. Therefore, during smallpox mass immunization, revaccination success assessment among multiple revaccinees is unnecessary.

Jean Yuan and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 862–866, https://doi.org/10.1093/cid/cir005

Botulism is a rare neurological disease. During 1993–2006, we identified 17 California injection drug users (IDUs) with recurrent wound botulism (WB); most injected black tar heroin subcutaneously. WB can recur among IDUs necessitating timely diagnosis and early botulinum antitoxin administration.

Jonas Marschall and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 867–872, https://doi.org/10.1093/cid/cir062

The effect of antibiotic exposure on the yield of biopsy cultures from patients with hematogenous vertebral osteomyelitis was evaluated in a retrospective study. Open (compared to percutaneous) biopsy predicted positive cultures. Receivingpre-biopsy antibiotics did not affect the diagnostic yield.

Billy E. Ngasala and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 873–882, https://doi.org/10.1093/cid/cir066

We assessed cure rates and safety of artemether-lumefantrine in Tanzanian children with uncomplicated Plasmodium falciparum malaria after supervised and unsupervised intake during extended follow-up periods after initial and repeated treatment. Artemetherlumefantrine was safe and highly efficacious even after unsupervised intake.

Jeremy D. Keenan and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 883–888, https://doi.org/10.1093/cid/cir069

During a mass azithromycin campaign for trachoma, all-cause and infectious mortality rates were lower in treated children compared to untreated children. Treated children had a lower mortality rate even when compared only to members of the same household.

REVIEW ARTICLE

Brian L. Pearlman and Nomi Traub
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 889–900, https://doi.org/10.1093/cid/cir076

A sustained virologic response (SVR) to antiviral therapy for chronic hepatitis C infection is a clinically meaningful therapeutic endpoint and represents a cure. Achieving SVR engenders amelioration of histological damage and a reduction in critical clinical endpoints like liver-related death.

VIEWPOINTS

Matteo Zignol and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 901–906, https://doi.org/10.1093/cid/cir081

Availability of new diagnostic tools and global commitment towards universal access to tuberculosis care will accelerate capacity of resource-limited countries to monitor anti-tuberculosis drug resistance. Special surveys will be replaced by routine surveillance of drug resistance linked to patient care.

BRIEF REPORT

Jennifer A. Johnson and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 907–909, https://doi.org/10.1093/cid/cir033

PHOTO QUIZ

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page 910, https://doi.org/10.1093/cid/cir004

INVITED ARTICLES

Vaccines

Paul Fine and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 911–916, https://doi.org/10.1093/cid/cir007

Medical Microbiology

John D. Turnidge and on behalf of the Subcommittee on Antimicrobial Susceptibility Testing of the Clinical and Laboratory Standards Institute
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 917–924, https://doi.org/10.1093/cid/cir031

HIV/AIDS

Timothy J. Wilkin and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 925–928, https://doi.org/10.1093/cid/cir072
Heather J. Ribaudo and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 929–940, https://doi.org/10.1093/cid/ciq244

In this analysis of 5056 HIV-1 infected individuals initiating randomized antiretroviral treatment in clinical trials, abacavircontaining regimens did not appear associated with increased risk of myocardial infarction (MI). Classic cardiovascular disease risk factors were the strongest predictors of MI.

Andy I. Choi and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 941–944, https://doi.org/10.1093/cid/ciq239
Thuy Le and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 945–952, https://doi.org/10.1093/cid/cir028

Penicilliosis made up 4.4% of all AIDS admissions and increased approximately 30% in rainy months. In-hospital mortality was 20% and associated with injection drug use, shorter illness, absence of fever or skin lesions, respiratory difficulty, and degree of thrombocytopenia.

Andrew Prendergast and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 953–956, https://doi.org/10.1093/cid/cir029

ANSWER TO THE PHOTO QUIZ

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 957–959, https://doi.org/10.1093/cid/cir009

CORRESPONDENCE

Marco Floridia and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 960–962, https://doi.org/10.1093/cid/cir040

BOOK REVIEWS

Victor D. Rosenthal
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 963–964, https://doi.org/10.1093/cid/ciq211
Erik R. Dubberke and Carey-Ann D. Burnham
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages 964–965, https://doi.org/10.1093/cid/cir038
Paul G. Auwaerter
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page 965, https://doi.org/10.1093/cid/cir083

ERRATA

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page 966, https://doi.org/10.1093/cid/cir060
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page 967, https://doi.org/10.1093/cid/cir061

ELECTRONIC ARTICLES

Floor L. Pietersma and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages e144–e148, https://doi.org/10.1093/cid/cir002

We investigated the role of donor cytomegalovirus (CMV) serostatus on reactivation of CMV infection in CMV-infected transplant recipients. Reactivation of CMV infection occurred more frequently in patients receiving a CMV positive graft but was less severe than in patients receiving a CMV-negative graft. These data suggest roles for both virus as well as CMV-specific immunity present in the graft.

Seong Yeon Park and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages e149–e152, https://doi.org/10.1093/cid/cir027

The sensitivities of the serum and bronchoalveolar lavage galactomannan (GM) assays in 48 patients with pulmonary aspergilloma were 38% (13 of 34; 95% confidence interval [CI], 22%–56%) and 92% (33 of 36; 95% CI, 78%–98%), respectively. The positivity of serum GM assays was significantly higher in patients with hemoptysis than in those without hemoptysis (52% vs 9%; P 5 .02).

Guang Xue He and others
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Pages e153–e156, https://doi.org/10.1093/cid/cir075

This investigation of tuberculosis (TB) treatment regimens in 6 TB hospitals in China showed that only 18% of patients with new cases and 9% of patients with retreatment cases were prescribed standard TB treatment regimens. Adherence to treatment guidelines needs to be improved in TB hospitals to control multidrug-resistant TB in China.

COVER

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page NP, https://doi.org/10.1093/cid/cir241

STANDING MATERIAL

Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page NP, https://doi.org/10.1093/cid/cir240
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page NP, https://doi.org/10.1093/cid/cir242
Clinical Infectious Diseases, Volume 52, Issue 7, 1 April 2011, Page NP, https://doi.org/10.1093/cid/cir243
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close